EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA)

EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA)

.

Bibliographic Details
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Online Access:	https://www.rpcardio.online/jour/article/view/12

Similar Items

EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA)
Published: (2015-09-01)

EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA)
Published: (2015-09-01)

Update on evidence for treatment with ranolazine in stable angina
by: Federico Carbone, et al.
Published: (2013-10-01)

Update on ranolazine in the management of angina
by: Codolosa JN, et al.
Published: (2014-06-01)

Effects of ranolazine on various outcomes in patients with stable angina: an updated meta-analysis
by: Athanasios Manolis, et al.
Published: (2023-05-01)

Emerging clinical role of ranolazine in the management of angina
by: David S Vadnais, et al.
Published: (2010-10-01)

Real-World Data from the Use of Ranolazine in Patients with Stable Angina Pectoris: The RANGER Study
by: Christoforos Olympios, et al.
Published: (2024-03-01)

The Role of Ranolazine for the Treatment of Residual Angina beyond the Percutaneous Coronary Revascularization
by: Simone Calcagno, et al.
Published: (2020-07-01)

Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes
by: Velia Cassano, et al.
Published: (2022-12-01)

Lipid profile and markers of vascular inflammation in patients with stable angina in the presence and absence of type 2 diabetes mellitus
by: Tatiana I. Petelina, et al.
Published: (2017-08-01)

Ranolazine as an additional antianginal therapy in patients with stable symptomatic coronary artery disease
by: Benjamín Sanfuentes, et al.
Published: (2018-11-01)

Comparison of pharmacokinetic parameters of ranolazine between diabetic and non-diabetic rats
by: Habibeh Mashayekhi-sardoo, et al.
Published: (2022-07-01)

MODERN DRUG THERAPY OF THE CHRONIC STABLE ANGINAE (REVIEW)
by: V. P. Lupanov
Published: (2017-11-01)

RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Ranolazine: A Contemporary Review
by: Erin Rayner‐Hartley, et al.
Published: (2016-03-01)

Management of stable angina.
by: Yusuf, S, et al.
Published: (2009)

Improvement of Vascular Insulin Sensitivity by Ranolazine
by: Sol Guerra-Ojeda, et al.
Published: (2023-08-01)

Updating guidelines on stable angina.
by: Lancaster, T, et al.
Published: (2001)

Serum and plasma myeloperoxidase in acute coronary syndrome and chronic stable angina
by: Hoe, Ng Wai
Published: (2011)

Diagnosis and Management of Chronic Stable Angina: Clinical Guidelines in Primary Care
by: Mehdi Hashemi, et al.
Published: (2012-11-01)

EVALUATION OF CARDIAC SYSTOLIC FUNCTION IN PATIENTS WITH CHRONIC STABLE ANGINA AND NORMAL RESTING ELECTROCARDI-OGRAM
by: Omid Hashemi fard, et al.
Published: (2010-12-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
by: James A. Coleman, et al.
Published: (2024-04-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
by: Coleman, JA, et al.
Published: (2024)

Tailor treatment to the patient in stable angina.
by: Taggart, D
Published: (2011)

GUIDELINES ON THE MANAGEMENT OF STABLE ANGINA PECTORIS
Published: (2016-01-01)

GUIDELINES ON THE MANAGEMENT OF STABLE ANGINA PECTORIS
Published: (2016-01-01)

CHANGES IN THE CYTOKINE STATUS WITH STABLE ANGINA
by: E. K. Gordeeva, et al.
Published: (2016-03-01)

Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture
by: Adrián Jordá, et al.
Published: (2022-10-01)

Risk factors in blood for attacks of angina in patients with coronavirus disease 2019 and stable angina
by: Song Geng, et al.
Published: (2023-06-01)

Prognostic significance of proinflammatory factors in patients with progressive angina pectoris and type 2 diabetes mellitus
by: Olga Leonidovna Barbarash, et al.
Published: (2012-12-01)

CLINICAL EFFECTIVENESS AND SAFETY OF IVABRADINE USE IN PATIENTS WITH UNSTABLE ANGINA AND DIABETES MELLITUS TYPE 2
by: A. I. Kondratiev
Published: (2014-07-01)

CLINICAL EFFECTIVENESS AND SAFETY OF IVABRADINE USE IN PATIENTS WITH UNSTABLE ANGINA AND DIABETES MELLITUS TYPE 2
by: A. I. Kondratiev
Published: (2014-07-01)

CLINICAL EFFECT OF TESTOSTERONE IN MEN WITH STABLE ANGINA
by: A. Ya. Kravchenko, et al.
Published: (2016-01-01)

NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
by: Y. V. Gavrilov, et al.
Published: (2015-12-01)

GUIDELINES ON THE MANAGEMENT OF STABLE ANGINA PECTORIS (ENDING)
by: K. Fox, et al.
Published: (2015-12-01)

The specifics of using nitrates in the treatment of stable angina
by: A. G. Evdokimova, et al.
Published: (2015-12-01)

METABOLIC PLATELET STATUS IN PATIENTS WITH STABLE ANGINA
by: I. Yu. Grinstein, et al.
Published: (2013-12-01)

CLINICAL EFFECT OF TESTOSTERONE IN MEN WITH STABLE ANGINA
by: A. Ya. Kravchenko, et al.
Published: (2016-01-01)

GUIDELINES ON THE MANAGEMENT OF STABLE ANGINA PECTORIS (ENDING)
by: K. Fox, et al.
Published: (2015-12-01)